Novel Compounds as GIPR Agonists for Treating Type 2 Diabetes Mellitus and Obesity

Read full text
Authors: Ram W. Sabnis
Cited by: 1
References: 6

Abstract

High Resolution Image Download MS PowerPoint Slide Provided herein are novel compounds as GIPR agonists, pharmaceutical compositions, use of such compounds in treating type 2 diabetes mellitus and obesity, and processes for preparing such compounds.

Fields of Study & Subjects

Diabetes Treatment and Management Pharmacology and Obesity Treatment Regulation of Appetite and Obesity

Publication details

Journal / source
ACS Medicinal Chemistry Letters
Publisher
American Chemical Society (ACS)
Volume
17
Issue
2
Pages
322–324
Publication date
23 January 2026
Language
EN